{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:57:02Z","timestamp":1789131422143,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["UMR1291"],"award-info":[{"award-number":["UMR1291"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jcv.2026.105939","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:20:25Z","timestamp":1774311625000},"page":"105939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["HIV-1 gag genotypic resistance testing using short-read and long-read next-generation sequencing technologies"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8637-6695","authenticated-orcid":false,"given":"Camille","family":"Vellas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Poiteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Carcenac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Ranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Demmou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiane","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Delobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Izopet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2026.105939_bib1","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa2115542","article-title":"Capsid inhibition with lenacapavir in multidrug-resistant HIV-1 infection","volume":"386","author":"Segal-Maurer","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2026.105939_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41586-020-2443-1","article-title":"Clinical targeting of HIV capsid protein with a long-acting small molecule","volume":"584","author":"Link","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jcv.2026.105939_bib3","article-title":"Efficacy and safety of weekly islatravir plus lenacapavir in PLWH at 24 weeks: a phase II study","author":"Colson","year":"2024","journal-title":"CROI"},{"key":"10.1016\/j.jcv.2026.105939_bib4","article-title":"Efficacy and safety of lenacapavir, teropavimab, and zinlirvimab: phase II week 26 primary outcome","author":"Mponponsuo","year":"2025","journal-title":"CROI"},{"key":"10.1016\/j.jcv.2026.105939_bib5","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa2407001","article-title":"PURPOSE 1 study team, twice-yearly lenacapavir or daily F\/TAF for HIV prevention in cisgender women","volume":"391","author":"Bekker","year":"2024","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.jcv.2026.105939_bib6","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMoa2411858","article-title":"Twice-yearly lenacapavir for HIV prevention in men and gender-diverse persons","volume":"392","author":"Kelley","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2026.105939_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00334-24","article-title":"No antagonism or cross-resistance and a high barrier to the emergence of resistance in vitro for the combination of islatravir and lenacapavir","volume":"68","author":"Diamond","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2026.105939_bib8","article-title":"The genetic barrier to resistance to LEN is not affected by non-B subtypes or treatment exposure","author":"Bartolini","year":"2025","journal-title":"CROI"},{"key":"10.1016\/j.jcv.2026.105939_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29951","article-title":"Comparison of short-read and long-read next-generation sequencing technologies for determining HIV-1 drug resistance","volume":"96","author":"Vellas","year":"2024","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2026.105939_bib10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/v15020571","article-title":"From capillary electrophoresis to deep sequencing: an improved HIV-1 drug resistance assessment solution using in vitro diagnostic (IVD) assays and software","volume":"15","author":"Mohamed","year":"2023","journal-title":"Viruses"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653226000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653226000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T17:15:12Z","timestamp":1779556512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653226000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":10,"alternative-id":["S1386653226000284"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2026.105939","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-1 gag genotypic resistance testing using short-read and long-read next-generation sequencing technologies","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2026.105939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105939"}}